Table 1. Baseline characteristics of patients with and without AF recurrence.
| Characteristics | Patients with recurrence (n=22) | Patients without recurrence (n=78) | p |
|---|---|---|---|
| Age (years) | 60.0±7.2 | 53.8±11.2 | 0.003 |
| Sex (female/male) | 14/8 | 39/39 | 0.258 |
| Weight (kg) | 79.1±12.3 | 76.6±10.2 | 0.333 |
| Length (cm) | 163.6±11.4 | 165.7±7.9 | 0.418 |
| BMI (kg/m2) | 29.3±4.9 | 28.0±4.5 | 0.263 |
| Smoking | 5 (22.7) | 36 (46.8) | 0.044 |
| Diabetes | 6 (27.3) | 7 (9.1) | 0.026 |
| Hypertension | 18 (81.8) | 29 (37.7) | <0.001 |
| CAD history | 3 (13.6) | 6 (7.8) | 0.400 |
| CHA2DS2VASc score | 2.22±1.41 | 1.29±1.20 | 0.018 |
| HAS-BLED score | 0.90±0.68 | 0.38±0.51 | 0.004 |
| Modified EHRA score | 1.86±0.35 | 1.84±0.39 | 0.803 |
| ACEI or ARB | 15 (68.2) | 25 (32.5) | 0.003 |
| Beta blocker | 22 (100) | 74 (96.1) | 0.347 |
| Amiadarone | 5 (22.7) | 7 (9.1) | 0.084 |
| Propafenon | 3 (13.6) | 7 (9.1) | 0.533 |
| Oral anticoagulants | 17 (77.3) | 42 (55.3) | 0.063 |
Values are presented as mean±SD or number of patients (%). Bold styled values are statistically significant.
ACEI = angiotensin converting enzyme inhibitor; AF = atrial fibrillation; ARB = angiotensin receptor blocker; BMI = body mass index; CAD = coronary artery disease; EHRA = European Heart Rhythm Association; SD = standard deviation.